Lupin has enclosed a Press Release regarrding, launch of Ganirelix Acetate Injection, 250 mcg/0.5 mL, Single-Dose Prefilled Syringe, after having received an approval from the US FDA. This is considered as a disclosure pursuant to Regulation 30 of the Listing Regulations.
The above information is a part of company’s filings submitted to BSE.